1. Home
  2. CRON vs IBTA Comparison

CRON vs IBTA Comparison

Compare CRON & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • IBTA
  • Stock Information
  • Founded
  • CRON N/A
  • IBTA 2011
  • Country
  • CRON Canada
  • IBTA United States
  • Employees
  • CRON N/A
  • IBTA N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • IBTA
  • Sector
  • CRON Health Care
  • IBTA
  • Exchange
  • CRON Nasdaq
  • IBTA Nasdaq
  • Market Cap
  • CRON 809.4M
  • IBTA 926.1M
  • IPO Year
  • CRON N/A
  • IBTA 2024
  • Fundamental
  • Price
  • CRON $2.49
  • IBTA $35.08
  • Analyst Decision
  • CRON
  • IBTA Hold
  • Analyst Count
  • CRON 0
  • IBTA 10
  • Target Price
  • CRON N/A
  • IBTA $43.89
  • AVG Volume (30 Days)
  • CRON 2.0M
  • IBTA 269.7K
  • Earning Date
  • CRON 11-06-2025
  • IBTA 11-12-2025
  • Dividend Yield
  • CRON N/A
  • IBTA N/A
  • EPS Growth
  • CRON N/A
  • IBTA 2512.20
  • EPS
  • CRON 0.05
  • IBTA 2.84
  • Revenue
  • CRON $130,282,000.00
  • IBTA $367,604,000.00
  • Revenue This Year
  • CRON $19.67
  • IBTA N/A
  • Revenue Next Year
  • CRON $30.56
  • IBTA $1.61
  • P/E Ratio
  • CRON $51.19
  • IBTA $12.15
  • Revenue Growth
  • CRON 28.01
  • IBTA 3.49
  • 52 Week Low
  • CRON $1.60
  • IBTA $22.50
  • 52 Week High
  • CRON $3.16
  • IBTA $79.80
  • Technical
  • Relative Strength Index (RSI)
  • CRON 45.90
  • IBTA 77.69
  • Support Level
  • CRON $2.44
  • IBTA $32.06
  • Resistance Level
  • CRON $2.57
  • IBTA $33.30
  • Average True Range (ATR)
  • CRON 0.10
  • IBTA 1.14
  • MACD
  • CRON -0.02
  • IBTA 0.39
  • Stochastic Oscillator
  • CRON 12.99
  • IBTA 88.23

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About IBTA Ibotta Inc. Class A Common Stock

Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).

Share on Social Networks: